Tag: CSE:BUZZ

November 1, 2019

Pharmadrug Signs Major Canadian Supply Agreement with Canada House Wellness for German Distribution as German Governing Party Moves Closer to Recreational Cannabis Legislation

Pharmadrug Inc. is pleased to announce a multi-year supply agreement between subsidiary Pharmadrug Production GmbH and Canada House Wellness Group...
October 21, 2019

Aura Health Announces Name Change to Pharmadrug to Reflect Focus on Pharmaceutical Medicine

Aura Health Inc. ("Aura") (CSE:BUZZ, OTC:LMLLF) is pleased to announce that it has completed its name change from Aura Health...
October 9, 2019

Aura Health CEO: We’re Positioned to Capitalize on the German Cannabis Market

Aura Health CEO Daniel Cohen discusses his company’s progress in the European cannabis market, including the German medical cannabis market.
October 8, 2019

International Cannabis Industry Presenting Opportunity to Canadian Companies

Established Canadian producers are looking to expand into emerging international cannabis markets.
October 3, 2019

Aura Announces Extension of Maturity and Partial Repayment of Bridge Loan Facility

Aura Health Inc. is pleased to announce that the CAD$3 million bridge loan facility has been amended to mature in...
September 19, 2019

Aura’s Pharmadrug Signs Major Supply Agreement Setting Stage for Brand Launch & Expanded Distribution

Aura Health Inc. is pleased to announce a multi-year supply agreement between 80% owned subsidiary Pharmadrug Production GmbH and My...
August 13, 2019

Aura Announces Pharmadrug Operational & Investor Relations Update

Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ, OTCQB:LMLLF) is pleased to provide an operational update on Pharmadrug Production GmbH...